TAO Synergies TAOX
NASDAQ TAOX
$4.07 +0.06 (+1.50%)
As of: Sep 9, 2026 · 11:20 AM EDT

TAO Synergies (TAOX) Preferred Dividend Payments (2023 - 2026)

TAO Synergies' (TAOX) quarterly Preferred Dividend Payments came in at $201045.0 in Q2 2026, up 95.69% on a YoY basis from $102739.0 in Q2 2025, and down 1.15% quarter-over-quarter from $203384.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Preferred Dividend Payments (2023 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Preferred Dividend Payments for 4 consecutive years, with $201045.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Preferred Dividend Payments rose 95.69% year-over-year to $201045.0; the trailing twelve-month figure through Jun 2026 stood at $538646.0 (down 13.1% YoY), and the FY2025 full-year result was $338359.0, down 57.16% from the prior year.
  • Preferred Dividend Payments eased to $201045.0 in Q2 2026 per TAOX's latest filing, from $203384.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $1.1 million in Q3 2023 and bottomed at $45210.0 in Q3 2025.
  • Historically, Preferred Dividend Payments has averaged $255747.9 across 4 years, with a median of $202214.5 in 2026.
  • The sharpest annual moves came in 2025 and 2026: Preferred Dividend Payments sank 85.26% in 2025, then surged 100.57% in 2026.
  • Over 4 years, Preferred Dividend Payments stood at $233497.0 in 2023, then slumped by 53.32% to $108990.0 in 2024, then dropped by 18.33% to $89007.0 in 2025, then soared by 125.88% to $201045.0 in 2026.
  • According to Business Quant data, Preferred Dividend Payments over the past three periods registered $201045.0, $203384.0, and $89007.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Amgen 212.35 Bn 198.36 Bn 7.24 Bn -
2 Gilead Sciences 181.19 Bn 178.01 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.48 Bn 124.62 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.59 Bn 74.60 Bn 3.93 Bn -
5 Argenx Se 61.45 Bn 56.27 Bn 1.37 Bn -
6 Moderna 54.89 Bn 49.75 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.21 Bn 30.90 Bn 992.69 Mn -
8 Biogen 31.38 Bn 30.10 Bn 1.96 Bn -
9 Roivant Sciences 29.81 Bn 29.81 Bn 1.16 Mn -
10 TAO Synergies 30.41 Mn 30.41 Mn - 201,045.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 201,045.00
Mar 31, 2026 203,384.00
Dec 31, 2025 89,007.00
Sep 30, 2025 45,210.00
Jun 30, 2025 102,739.00
Mar 31, 2025 101,403.00
Dec 31, 2024 108,990.00
Sep 30, 2024 306,725.00
Jun 30, 2024 155,735.00
Mar 31, 2024 218,459.00
Dec 31, 2023 233,497.00
Sep 30, 2023 1.12 Mn
Jun 30, 2023 423,575.00
Mar 31, 2023 266,074.00